4//SEC Filing
Pinion John Richard 4
Accession 0000950170-25-032785
CIK 0001515673other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 8:12 PM ET
Size
12.8 KB
Accession
0000950170-25-032785
Insider Transaction Report
Form 4
Pinion John Richard
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2025-03-01+26,074→ 26,074 totalExercise: $42.92Exp: 2035-03-01→ Commmon Stock (26,074 underlying) - Award
Common Stock
2025-03-01+18,443→ 122,205 total - Award
Common Stock
2025-03-01+14,494→ 103,762 total - Sale
Common Stock
2025-03-03$42.10/sh−14,439$607,882→ 107,766 total - Tax Payment
Common Stock
2025-03-03$42.92/sh−31$1,331→ 108,428 total
Footnotes (8)
- [F1]Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date
- [F2]Represents shares of common stock which previously granted performance stock units were converted on March 1, 2025 upon certification of the performance metric.
- [F3]Represents shares sold to pay required tax withholdings due to the vesting of RSUs.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.77 to $42.90 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F5]Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.
- [F6]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
- [F7]Includes 693 shares acquired under the Company's Amended & Restated Employee Stock Purchase Plan on April 30, 2024
- [F8]On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.
Documents
Issuer
Ultragenyx Pharmaceutical Inc.
CIK 0001515673
Entity typeother
Related Parties
1- filerCIK 0001648096
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 8:12 PM ET
- Size
- 12.8 KB